Invesaro

Stocks Comparison

Becton Dickinson vs Resmed: revenue, profit, margins and growth compared

Becton Dickinson brought in $21.8B of revenue in fiscal 2025, Resmed $5.7B in fiscal 2026. Revenue changed by +8.2% at Becton Dickinson and +9.9% at Resmed on the year before, so Resmed grew faster. Becton Dickinson kept 7.7% of its revenue as net profit, Resmed 26.9%. Free cash flow was $2.7B at Becton Dickinson and $1.6B at Resmed.

Side by side, latest fiscal year

BDXRMD
Fiscal year endedFY2025 (September 30, 2025)FY2026 (June 30, 2026)
Revenue$21.8B$5.7B
Revenue growth+8.2%+9.9%
Net income$1.7B$1.5B
Net margin7.7%26.9%
Free cash flow$2.7B$1.6B
Free cash flow margin12.2%29.2%
Earnings per share (diluted)$5.82$10.43
Cash$567M$1.5B
Debt$17.6B$399.4M
Price to earnings31.721.3
Market value$50.2B$32B
Dividend yield2.26%1.08%
Rank by revenue in sector#27 of 742 · Health care#61 of 742 · Health care

Over the years

Revenue
BDX FY2018: $16BBDX FY2019: $17.3BBDX FY2020: $16.1BBDX FY2021: $19.1BBDX FY2022: $18.9BBDX FY2023: $19.4BBDX FY2024: $20.2BBDX FY2025: $21.8BRMD FY2019: $2.6BRMD FY2020: $3BRMD FY2021: $3.2BRMD FY2022: $3.6BRMD FY2023: $4.2BRMD FY2024: $4.7BRMD FY2025: $5.1BRMD FY2026: $5.7BFY18FY19FY20FY21FY22FY23FY24FY25FY26
BDX $21.8BRMD $5.7B
Net income
BDX FY2018: $311MBDX FY2019: $1.2BBDX FY2020: $874MBDX FY2021: $2.1BBDX FY2022: $1.8BBDX FY2023: $1.5BBDX FY2024: $1.7BBDX FY2025: $1.7BRMD FY2019: $404.6MRMD FY2020: $621.7MRMD FY2021: $474.5MRMD FY2022: $779.4MRMD FY2023: $897.6MRMD FY2024: $1BRMD FY2025: $1.4BRMD FY2026: $1.5BFY18FY19FY20FY21FY22FY23FY24FY25FY26
BDX $1.7BRMD $1.5B
Net margin
BDX FY2018: 1.9%BDX FY2019: 7.1%BDX FY2020: 5.4%BDX FY2021: 10.9%BDX FY2022: 9.4%BDX FY2023: 7.7%BDX FY2024: 8.4%BDX FY2025: 7.7%RMD FY2019: 15.5%RMD FY2020: 21.0%RMD FY2021: 14.8%RMD FY2022: 21.8%RMD FY2023: 21.3%RMD FY2024: 21.8%RMD FY2025: 27.2%RMD FY2026: 26.9%FY18FY19FY20FY21FY22FY23FY24FY25FY26
BDX 7.7%RMD 26.9%
Revenue growth
BDX FY2019: +8.2%BDX FY2020: -7.0%BDX FY2021: +19.0%BDX FY2022: -1.4%BDX FY2023: +2.7%BDX FY2024: +4.2%BDX FY2025: +8.2%RMD FY2020: +13.4%RMD FY2021: +8.1%RMD FY2022: +11.9%RMD FY2023: +18.0%RMD FY2024: +10.9%RMD FY2025: +9.8%RMD FY2026: +9.9%FY19FY20FY21FY22FY23FY24FY25FY26
BDX +8.2%RMD +9.9%
Free cash flow
BDX FY2018: $2BBDX FY2019: $2.4BBDX FY2020: $2.8BBDX FY2021: $3.5BBDX FY2022: $1.5BBDX FY2023: $2.1BBDX FY2024: $3.1BBDX FY2025: $2.7BRMD FY2019: $390.3MRMD FY2020: $706.9MRMD FY2021: $634MRMD FY2022: $216.3MRMD FY2023: $573.6MRMD FY2024: $1.3BRMD FY2025: $1.7BRMD FY2026: $1.6BFY18FY19FY20FY21FY22FY23FY24FY25FY26
BDX $2.7BRMD $1.6B

Fiscal years as each company reports them; the two may end in different months.

Questions about Becton Dickinson and Resmed

Which is bigger by revenue, Becton Dickinson or Resmed?

Becton Dickinson is bigger by revenue: $21.8B in fiscal 2025, against $5.7B for Resmed in fiscal 2026.

Which keeps more of its revenue as profit, Becton Dickinson or Resmed?

Becton Dickinson had a net margin of 7.7% in fiscal 2025; Resmed had 26.9% in fiscal 2026.

Which grew revenue faster, Becton Dickinson or Resmed?

In their latest fiscal years revenue changed by +8.2% at Becton Dickinson and +9.9% at Resmed.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies